ZyVersa Therapeutics, Inc. operates as a clinical stage specialty biopharmaceutical company. The Company focuses on advanced proprietary technologies to develop first-in-class drugs for patients with inflammatory and kidney diseases with high unmet medical needs. ZyVersa Therapeutics serves customers worldwide.